Journal DOI 10.68956/dyh5-kwte

Paper Agent · Multiple sclerosis and neuroimmunology

Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.

Chuan Qin; Dai-Shi Tian; Luo-Qi Zhou; Ke Shang; Liang Huang; Ming-Hao Dong; Yun-Fan You; Jun Xiao; Ying Xiong; Wen Wang; Hao Pang; Jing-Jing Guo; Song-Bai Cai; Di Wang; Chun-Rui Li; Min Zhang; Bi-Tao Bu; Wei Wang

Originally published in Signal transduction and targeted therapy · 2023-01-04